company background image
3933 logo

United Laboratories International Holdings SEHK:3933 Voorraadrapport

Laatste prijs

HK$10.80

Marktkapitalisatie

HK$19.5b

7D

-2.7%

1Y

29.7%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

The United Laboratories International Holdings Limited

SEHK:3933 Voorraadrapport

Marktkapitalisatie: HK$19.5b

3933 Overzicht aandelen

United Laboratories International Holdings Limited, een beleggingsholding, houdt zich bezig met onderzoek en ontwikkeling, productie, distributie en verkoop van farmaceutische producten.

The United Laboratories International Holdings Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor United Laboratories International Holdings
Historische aandelenkoersen
Huidige aandelenkoersHK$10.80
52 Week HoogtepuntHK$11.74
52 Week LaagHK$6.52
Bèta0.083
11 maand verandering-1.64%
3 maanden verandering25.14%
1 Jaar Verandering29.65%
33 jaar verandering115.14%
5 jaar verandering117.30%
Verandering sinds IPO199.17%

Recent nieuws en updates

The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Oct 23
The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Aug 30
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Recent updates

The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Oct 23
The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market

Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Aug 30
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching

Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

Feb 29
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified

The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

Jan 04
The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement

United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

Dec 14
United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt

With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Nov 26
With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case

Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Aug 31
Is United Laboratories International Holdings (HKG:3933) A Risky Investment?

Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

Aug 10
Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?

United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Dec 23
United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet

Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Oct 19
Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?

Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Aug 30
Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?

Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

Mar 08
Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?

The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

Feb 18
The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It

The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 03
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

Jan 19
Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?

We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

Jan 04
We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide

These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Dec 20
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

Dec 07
What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?

The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Nov 23
The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?

Rendement voor aandeelhouders

3933HK PharmaceuticalsHK Markt
7D-2.7%-7.2%-1.0%
1Y29.7%-2.9%15.0%

Rendement versus industrie: 3933 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.

Rendement versus markt: 3933 exceeded the Hong Kong Market which returned 15% over the past year.

Prijsvolatiliteit

Is 3933's price volatile compared to industry and market?
3933 volatility
3933 Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.3%

Stabiele aandelenkoers: 3933 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatiliteit in de loop van de tijd: 3933's weekly volatility (7%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
199015,000n/awww.tul.com.cn

United Laboratories International Holdings Limited, een beleggingsholding, houdt zich bezig met onderzoek en ontwikkeling, productie, distributie en verkoop van farmaceutische producten. Het is actief in drie segmenten: Bulkgeneesmiddelen, Tussenproducten en Eindproducten. Het bedrijf biedt orale antibiotica, antimicrobiële middelen voor injectie, antikoudheidsproducten, hoestmedicijnen, oogheelkundige geneesmiddelen, antivirale geneesmiddelen, geneesmiddelen tegen hepatitis B, diabetesmedicijnen, huidmedicijnen voor uitwendig gebruik, cardiovasculaire en cerebrovasculaire geneesmiddelen, amoxicillineproducten, geneesmiddelen voor het zenuwstelsel, vitaminen, diergeneesmiddelen en vrije gelatinecapsules.

The United Laboratories International Holdings Limited Samenvatting

Hoe verhouden de winst en inkomsten van United Laboratories International Holdings zich tot de beurswaarde?
3933 fundamentele statistieken
MarktkapitalisatieHK$19.48b
Inkomsten(TTM)HK$3.19b
Inkomsten(TTM)HK$15.36b

6.2x

Koers/Winstverhouding

1.3x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
3933 resultatenrekening (TTM)
InkomstenCN¥14.01b
Kosten van inkomstenCN¥7.54b
BrutowinstCN¥6.47b
Overige uitgavenCN¥3.56b
InkomstenCN¥2.91b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)1.60
Brutomarge46.15%
Nettowinstmarge20.76%
Schuld/Eigen Vermogen Verhouding18.0%

Hoe presteerde 3933 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

5.6%

Huidig dividendrendement

27%

Uitbetalingsratio